^
Association details:
Biomarker:TNFA elevation
Cancer:Breast Cancer
Regimen:
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
New
Title:

Tumour necrosis factor-alpha levels as predictor factor on clinical response of anthracycline-based neoadjuvant chemotherapy in locally advance breast cancer patients: experimental research

Published date:
04/03/2023
Excerpt:
Participants received anthracycline-based neoadjuvant chemotherapy (cyclophosphamide of 500 mg/m2, doxorubicin of 50 mg/m2 and fluorouracil/5FU of 500 mg/m2) for 3 cycles….Based on cutoff 1, most participants with high TNF-α levels also had a negative response of 83.3% and those with low TNF-α levels also had a positive response of 75% (P<0.001)....TNF-α levels predict clinical response for anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients.
DOI:
10.1097/MS9.0000000000000424